ArticleMolecular neurodegeneration advances2026
Mild traumatic brain injury promotes chronic cerebrovascular inflammation and glymphatic suppression.
Article in Molecular neurodegeneration advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Background: Repetitive exposure to mild traumatic brain injury (r-mTBI) increases the risk for chronic traumatic encephalopathy (CTE) and vascular contributions to cognitive impairment and dementia (VCID). Given the strong association between head trauma exposure, persistent inflammatory endothelial damage, and glymphatic impairment, we hypothesized that cerebrovascular inflammation following r-mTBI may play a causal role in mediating post-traumatic gliovascular dysregulation, and the development of VCID pathology. Methods: To provide insight into potential mechanisms and upstream regulatory factors, we first examined the gliovascular transcriptional profile in post-mortem chronic human mTBI and r-mTBI tissue. Experimental validation was performed in a mouse model of chronic r-mTBI using transcriptomic, ultrastructural, biochemical, and functional assessments. Results: We observed chronic cerebrovascular inflammation following r-mTBI, characterized by cerebrovascular macrophage recruitment, eNOS dysregulation, oxidative stress, hypoxia, and mitochondrial damage. This coincided with a temporal shift in macrophage activation, resulting in the emergence of a chronic, pro-inflammatory, oxidative cerebrovascular profile. Notably, we showed that chronic r-mTBI also deteriorates the cerebrovascular basement membrane components that anchor astrocyte endfeet to the cerebrovasculature, manifesting in perivascular AQP4 mislocalization and glymphatic suppression. Conclusion: These results suggest that repetitive head trauma can induce robust, persistent endothelial dysfunction, inflammation, oxidative stress, and metabolic dysregulation, that disrupts perivascular waste elimination pathways at the gliovascular interface early in the post-injury disease process. Graphical Abstract: Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s44477-026-00053-w.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.